Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells

FASEB Journal

Volumn 20, Issue 11, 2006, Pages 1775-1784

  Tünnemann, Gisela ^a   Martin, Robert M ^a   Haupt, Simone ^b   Patsch, Christoph ^b   Edenhofer, Frank ^b   Cardoso, M Cristina ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Cell penetrating peptide; Cre recombinase; PBD; PCNA; Protein transduction

Indexed keywords

CELL PENETRATING PEPTIDE; CYCLINE; HYBRID PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; CDKN1A PROTEIN, HUMAN; CRE RECOMBINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; INTEGRASE; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; BIOAVAILABILITY; BLEACHING; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL VACUOLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; MEMBRANE POTENTIAL; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; AMINO ACID SEQUENCE; ANIMAL; CELL; CELL CULTURE; CHEMISTRY; HUMAN; KINETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

MAMMALIA;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CELLS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE PRODUCTS, TAT; HUMANS; INTEGRASES; KINETICS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS;

EID: 33748648777     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-5523com     Document Type: Article

References (43)

1. Dietz, G. P., and Bdeltahr, M. (2004) Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell Neurosci. 27, 85-131
2. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590
3. Cardoso, M. C., and Leonhardt, H. (2002) Protein transduction: a novel tool for tissue regeneration. J. Biol. Chem. 383, 1593-1599
4. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017
5. Dom, G., Shaw-Jackson, C., Matis, C., Bouffioux, O., Picard, J. J., Prochiantz, A., Mingeot-Leclercq, M. P., Brasseur, R., and Rezsohazy, R. (2003) Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation. Nucleic Acids Res. 31, 556-561
6. Mai, J. C., Shen, H., Watkins, S. C., Cheng, T., and Robbins, P. D. (2002) Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J. Biol. Chem. 277, 30208-30218
7. Ziegler, A., Blatter, X. L., Seelig, A., and Seelig, J. (2003) Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry 42, 9185-9194
8. Mitchell, D. J., Kim, D. T., Steinman, L., Fathman, C. G., and Rothbard, J. B. (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318-325
9. Thoren, P. E., Persson, D., Isakson, P., Goksor, M., Onfelt, A., and Norden, B. (2003) Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307, 100-107
10. Rothbard, J. B., Jessop, T. C., and Wender, P. A. (2005) Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv. Drug Deliv. Rev. 57, 495-504
11. Scheller, A., Wiesner, B., Melzig, M., Bienert, M., and Oehlke, J. (2000) Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides. Eur. J. Biochem. 267, 6043-6050
12. Ziegler, A., Nervi, P., Durrenberger, M., and Seelig, J. (2005) The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44, 138-148
13. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840
14. Prochiantz, A. (2000) Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12, 400-406
15. Vives, E. (2003) Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions. J. Mol. Recognit. 16, 265-271
16. Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F., and Giacca, M. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 278, 34141-34149
17. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315
18. Caron, N. J., Quenneville, S. P., and Tremblay, J. P. (2004) Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem. Biophys. Res. Commun. 319, 12-20
19. Kaplan, I. M., Wadia, J. S., and Dowdy, S. F. (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control Release 102, 247-253
20. Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M., and Kuriyan, J. (1996) Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell 87, 297-306
21. Cardoso, M. C., Joseph, C., Rahn, H. P., Reusch, R., Nadal-Ginard, B., and Leonhardt, H. (1997) Mapping and use of a sequence that targets DNA ligase I to sites of DNA replication in vivo. J. Cell Biol. 139, 579-587
22. Montecucco, A., Rossi, R., Levin, D. S., Gary, R., Park, M. S., Motycka, T. A., Ciarrocchi, G., Villa, A., Biamonti, G., and Tomkinson, A. E. (1998) DNA ligase I is recruited to sites of DNA replication by an interaction with proliferating cell nuclear antigen: identification of a common targeting mechanism for the assembly of replication factories. EMBO J. 17, 3786-3795
23. Peitz, M., Pfannkuche, K., Rajewsky, K., and Edenhofer, F. (2002) Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. U. S. A. 99, 4489-4494
24. Caron, N. J., Torrente, Y., Camirand, G., Bujold, M., Chapdelaine, P., Leriche, K., Bresolin, N., and Tremblay, J. P. (2001) Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol. Ther. 3, 310-318
25. Cardoso, M. C., Leonhardt, H., and Nadal-Ginard, B. (1993) Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74, 979-992
26. Leonhardt, H., Rahn, H. P., Weinzierl, P., Sporbert, A., Cremer, T., Zink, D., and Cardoso, M. C. (2000) Dynamics of DNA replication factories in living cells. J. Cell Biol. 149, 271-280
27. Nolden, L., Edenhofer, F., Haupt, S., Koch, P., Wunderlich, F. T., Siemen, H., and Brustle, O. (2006) Site specific recombination in human ES cells induced by cell permeable Cre recombinase. Nat. Methods In press
28. Seewald, N., and Jakubke, H.-D. (2002) Peptides: Chemistry and Biology, Wiley-VCH, Weinheim, Germany
29. Jo, D., Nashabi, A., Doxsee, C., Lin, Q., Unutmaz, D., Chen, J., and Ruley, H. E. (2001) Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat. Biotechnol. 19, 929-933
30. Joshi, S. K., Hashimoto, K., and Koni, P. A. (2002) Induced DNA recombination by Cre recombinase protein transduction. Genesis 33, 48-54
31. Will, E., Klump, H., Heffner, N., Schwieger, M., Schiedlmeier, B., Ostertag, W., Baum, C., and Stocking, C. (2002) Unmodified Cre recombinase crosses the membrane. Nucleic Acids Res. 30, e59
32. Goddette, D. W., and Frieden, C. (1986) The kinetics of cytochalasin D binding to monomeric actin. J. Biol. Chem. 261, 15970-15973
33. Flanagan, M. D., and Lin, S. (1980) Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J. Biol. Chem. 255, 835-838
34. Aidley, D., and Stanfield, P. (1996) Ion Channels: Molecules in Action, Cambridge University Press, Cambridge, England
35. Watanabe, Y., Kameoka, S., Gopalakrishnan, V., Aldape, K. D., Pan, Z. Z., Lang, F. F., and Majumder, S. (2004) Conversion of myoblasts to physiologically active neuronal phenotype. Genes Dev. 18, 889-900
36. Ho, A. (2001) Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-475
37. Choi, M., Rolle, S., Wellner, M., Cardoso, M. C., Scheidereit, C., Luft, F. C., and Kettritz, R. (2003) Inhibition of NF-kappaB by a TAT-NEMO binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 102, 2259-2267
38. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261
39. Vives, E., Richard, J. P., Rispal, C., and Lebleu, B. (2003) TAT peptide internalization: seeking the mechanism of entry. Curr. Protein Pept. Sci. 4, 125-132
40. Fischer, R., Kohler, K., Fotin-Mleczek, M., and Brock, R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279, 12625-12635
41. Phair, R. D., and Misteli, T. (2000) High mobility of proteins in the mammalian cell nucleus. Nature 404, 604-609
42. Maga, G., and Hubscher, U. (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051-3060
43. Warbrick, E. (1998) PCNA binding through a conserved motif. Bioessays 20, 195-199